Due to high costs, treatments developed by multinational pharmaceutical corporations are difficult for Korean patients to access. As a result, Korean...
For adult patients with high-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), or diffuse large B-cell lymphoma (DLBCL) who have not previously...
Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) was approved by the Food and Drug Administration for use in adult and paediatric patients (12 years of age and...
Enfortumab vedotin-ejfv (Padcev, Astellas Pharma) and pembrolizumab (Keytruda, Merck) have been given accelerated approval by the Food and Drug Administration...
Retifanlimab-dlwr (Zynyz, Incyte Corporation) received fast approval from the Food and Drug Administration to treat adult patients with metastatic or recurrent...
Tumor Infiltrating Lymphocytes (TILs) therapy is an experimental cancer treatment that involves harvesting immune cells known as TILs from a patient's tumor,...
Esophageal cancer is a type of cancer that affects the esophagus, the muscular tube that connects the throat to the stomach. Here are some lesser-known facts...
The Food and Drug Administration (FDA) approved abemaciclib (Verzenio, Eli Lilly and Company) with endocrine therapy (tamoxifen or an aromatase inhibitor) for...
According to the actor from New Zealand's new biography, he has blood cancer and will require chemotherapy for the rest of his life. But while he unwinds on...
The goal of this clinical trial is to study the feasibility and efficacy of anti-MESO antigen receptors (CARs) T cell therapy for relapsed and refractory...
This research focuses on CAR-T cells killing B cells. Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by chronic inflammation of...
This is an open, single-arm, dose-escalation and multiple-dose study to evaluate the safety, tolerability and preliminary effectiveness of B7-H3-targeting...
This is a single-center, single-arm, open-label study. After meeting the eligibility criteria and enrolling on the trial, patients will undergo leukapheresis...
This is a single arm, open-label, single-center study. This study is indicated for relapsed or refractory BCMA/TACI positive relapsed and/or refractory...
This is a prospective, single-center, open-label, single-arm study, to evaluate the efficacy and safety of Anti-BCMA chimeric antigen receptor T cell...
This is a phase I, open-label, single-arm study conducted in China to evaluate the safety, tolerability, PK, and determine the recommended phase II dose (RP2D)...
Oricell is developing a number of CAR-T therapies and antibody candidates for solid tumors. In the Phase I trial presented at ASCO, a group of patients with...
China to open its borders for the first time since COVID pandemic outbreak. Borders will open for all types of visa. Check how to obtain medical visa for...
March month if observed as colorectal cancer awareness month. Colorectal cancer is second most deadly cancer on this planet and early diagnosis is required for...
Peter MacCallum Cancer Centre (Peter Mac) and Cartherics Pty Ltd have entered into a collaborative development programme to develop CAR T Cell therapy for...
As per the report published in the Journal of Bone Oncology, researchers from the University of East Anglia’s Norwich Medical School demonstrated, that the...
JANUARY 27, 2023—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing...
March 2023: CAR-T-cell therapy is a novel and effective cancer treatment modality that has revolutionised the treatment of cancer, particularly blood cancers....
March 2023: Several types of lymphoma, as well as certain leukaemias and multiple myeloma, can now be effectively treated with CAR-T therapy. Recent studies...
Feb 2023: Check out this tweet from American Cancer Society that shares conversation with Dr. Willie Goffney about perspective on cancer. Tweet says...
Feb 2023: Enhertu (trastuzumab deruxtecan) from AstraZeneca and Daiichi Sankyo has been approved as a monotherapy for the treatment of adult patients with...
Feb 2023: Hamsa Nandini, who was diagnosed with Grade III Invasive Carcinoma (Breast Cancer) in 2021, has updated her Instagram followers on her health status....
Feb 2023: According to data published in JAMA Oncology, the global economic cost of cancers is projected to reach $25,2 trillion in international dollars (INT)...
Check how the overall landscape of cancer treatment has changed in last few years. Even advance stage cancers can be effectively treated with latest...
Feb 2023: A single-institution phase 1 trial found that the use of CD22-directed chimeric antigen receptor (CAR) T-cell therapy after relapse on CD19-directed...
Feb 2023: In a Phase III study, a CAR T-cell therapy more than tripled progression-free survival compared with standard care for triple-class exposed multiple...
Feb 2023: The results of the trial demonstrated that a novel chimeric antigen receptor T-cell therapy elicited a response in adults with advanced large B-cell...
Feb 2023: The FDA has granted orphan drug status to CT103A, an experimental CAR T-cell therapy being developed by IASO Biotherapeutics and Innovent Biologics...
Feb 2023: IASO Biotherapeutics’ investigational CAR T-cell therapy for relapsed or refractory multiple myeloma (RRMM), CT103A, has received fast track...
Feb 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) was given FDA approval to treat adult patients with mismatch repair deficient (dMMR) recurrent or...
Feb 2023: For patients with unresectable locally advanced or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+, or IHC 2+/ISH-) breast...
Feb 2023: Elacestrant (Orserdu, Stemline Therapeutics, Inc.) has been approved by the Food and Drug Administration (FDA) for postmenopausal women or adult men...
Feb 2023: Accelerated approval is granted by FDA to pirtobrutinib (Jaypirca, Eli Lilly and Company) for relapsed or refractory mantle cell lymphoma. In BRUIN...
Feb 2023: For stage IB (T2a 4 cm), stage II, or stage IIIA non-small cell lung cancer, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda,...
Feb 2023: Zanubrutinib (Brukinsa, BeiGene USA, Inc.) is approved by FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). SEQUOIA was...
Feb 2023: Tucatinib (Tukysa, Seagen Inc.) and trastuzumab received accelerated approval from the Food and Drug Administration (FDA) for the treatment of RAS...
Bone marrow transplant is one of the services of Cancerfax, which is provided by the best surgeons, along with accommodation, translator, companion nurse, and...
RAMAT GAN, Israel – June, 2022 – Sheba Medical Center, Israel’s largest medical center and a Newsweek top-10 ranked world’s best hospital for the last...
What does local prostate cancer mean? In Liv Hospital Urology Clinic, HIFU is applied as the primary treatment approach in localized prostate cancer,...
Jan 2023: The Asan Medical Center (AMC) opened the first CAR-T cell treatment facility in the country after the government approved health insurance benefits...
Several notable cancer hospitals in India are known for their superior medical competence and cutting-edge technology. The Tata Memorial Hospital in Mumbai is...
Jan 2023: Mosunetuzumab-axgb (Lunsumio, Genentech, Inc.), a bispecific CD20-directed CD3 T-cell engager for adult patients with relapsed or refractory...
Jan 2023: The drug nadofaragene firadenovec-vncg (Adstiladrin, Ferring Pharmaceuticals) has been approved by the Food and Drug Administration for adult...
Jan 2023: Adagrasib (Krazati, Mirati Therapeutics, Inc.), a RAS GTPase family inhibitor, was given accelerated approval by the Food and Drug Administration...
Dec 2022: Atezolizumab (Tecentriq, Genentech, Inc.) has been approved by the Food and Drug Administration (FDA) for adult and paediatric patients with...
Dec 2022: Olutasidenib (Rezlidhia) capsules were approved by the Food and Drug Administration (FDA) for adult patients with relapsed or resistant acute...
Dec 2022: A new Monday-Wednesday-Friday dosing schedule for asparaginase erwinia chrysanthemi (recombinant)-rywn has been approved by the Food and Drug...
November 2022: For adult patients who have had one to three prior systemic treatment regimens and have folate receptor alpha (FR) positive, platinum-resistant...
November 2022: The combination of tremelimumab (Imjudo, AstraZeneca Pharmaceuticals), durvalumab (Imfinzi, AstraZeneca Pharmaceuticals), and platinum-based...
November 2022: The combination of doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide with brentuximab vedotin (Adcetris, Seagen, Inc.) has...
November 2022: The combination of cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) and platinum-based chemotherapy for adult patients with advanced...
November 2022: The first bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager, teclistamab-cqyv (Tecvayli, Janssen Biotech, Inc.), was given...
November 2022: The Food and Drug Administration approved tremelimumab (Imjudo, AstraZeneca Pharmaceuticals) in combination with durvalumab for adult patients...
November 2022: The Food and Drug Administration granted accelerated approval to futibatinib (Lytgobi, Taiho Oncology, Inc.) for adult patients with previously...
November 2022: Selpercatinib (Retevmo, Eli Lilly and Company) received accelerated approval from the Food and Drug Administration to treat adult patients with...
November 2022: In children aged one month and older with localised, non-metastatic solid tumours, the Food and Drug Administration has approved sodium...
November 2022: For adult patients with locally advanced or metastatic biliary tract cancer, the Food and Drug Administration has approved durvalumab (Imfinzi,...
November 2022: Pemigatinib (Pemazyre, Incyte Corporation) has been licenced by the Food and Drug Administration for use in people with relapsed or refractory...
Sept 2022: Ibrutinib (Imbruvica, Pharmacyclics LLC) was approved by the Food and Drug Administration for use in paediatric patients with chronic graft versus...
Sept 2022: The treatment of various tumours has been transformed by cell-based immunotherapy, often known as CAR-T cell therapy. In order to target and combat...
Sept 2022: According to a study published in the Journal of Clinical Investigation, an engineer at the University of Houston (UH) may have discovered a...
August 2022: The most apical portion of polarised epithelial and endothelial cells contains tight junctions, which are specialised membrane domains. The...
August 2022: For adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have a mutation resulting in mesenchymal-epithelial...
August 2022: For adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have a mutation resulting in mesenchymal-epithelial...
August 2022: Darolutamide (Nubeqa, Bayer HealthCare Pharmaceuticals Inc.) tablets combined with docetaxel were approved by the Food and Drug Administration...
August 2022: For adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH) breast cancer who have received prior chemotherapy in the...
July 2022: Crizotinib (Xalkori, Pfizer Inc.) was granted approval by the Food and Drug Administration (FDA) for the treatment of adult and paediatric...
July 2022: On July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation...
July 2022: According to the most recent research conducted by Emergen Research, the global market for CAR T-cells therapy reached a size of USD 1.29...
June 2022: According to the findings of a study that was just recently published by Stanford Medicine in mice, a cancer treatment that makes use of a...
April 2022: According to preliminary data from a phase I/II clinical trial that was presented during the AACR Annual Meeting 2022, which was held from April...
Nov 2021: The first clinical trial of South Korea’s homegrown next-generation chimeric antigen receptor T (CAR-T) cell therapy, which is designed to...
July 2022: Lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) has been approved by the Food and Drug Administration for adult patients with large...
July 2022: Dabrafenib (Tafinlar, Novartis) and trametinib (Mekinist, Novartis) received accelerated approval from the Food and Drug Administration for the...
June 2022: A small study of rectal cancer patients yielded extraordinary results: 100 percent of the individuals were in remission. The results were published...
June 2022: After two or more lines of systemic therapy, the FDA awarded tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) expedited approval...
June 2022: For the first-line therapy of individuals with advanced or metastatic esophageal squamous cell carcinoma (ESCC), the Food and Drug Administration...
June 2022: Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) in combination with azacitidine has been approved by the Food and Drug Administration for newly...
June 2022: The FDA has approved the drug azacitidine (Vidaza, Celgene Corp.) for children with newly diagnosed juvenile myelomonocytic leukaemia (JMML). The...
May 2022: Trametinib may become a new standard of care for recurring, low-grade serous ovarian cancer (Mekinist). According to study findings published in the...
May 2022: According to study findings published February 1 in the Journal of the National Cancer Institute, overweight or obese adults who lose more than 5...
May 2022: T-cell therapy has begun a vigorous attack on digestive system malignancies, and T-cell immunotherapy has triumphed over refractory tumours like...
May 2022: FDA approves clinical trial application of specific CAR-NK therapy FT536 in the treatment of solid tumours in a CAR-NK clinical trial. The FDA...
May 2022: Matthew is a 27-year-old patient with Acute Lymphoblastic Leukemia who was diagnosed in 2015. Unfortunately, the standard treatment of chemotherapy...
Induction therapy followed by stem cell transplant has maintained a role in the treatment of mantle cell lymphoma (MCL), according to James Gerson, MD, who...
April 2022: Adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen either in the...
April 2022: The Food and Drug Administration approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan, Advanced Accelerator Applications USA, Inc., a Novartis...
April 2022: Pembrolizumab (Keytruda, Merck) was approved by the Food and Drug Administration as a single agent for patients with advanced endometrial...
April 2022: The US Food and Drug Administration (FDA) has approved Opdualag (nivolumab and relatlimab-rmbw), a new, first-in-class fixed-dose combination of...
April 2022: The National Medical Products Administration (NMPA) of China has approved JW Therapeutics’ investigational new drug (IND) application for a...
April 2022: Normally, the cell manufacturing procedure for CAR T-cell therapy takes nine to fourteen days; however, researchers at the University of...
March 2022: Blood vessels are supposed to behave like trees, pouring oxygen into tissues in order for them to flourish and immune cells to clean infections...
March 2022: According to researchers at the UNC Lineberger Comprehensive Cancer Center, adding a tiny chemical to a treatment process called chimeric antigen...
Leukemia in childhood Leukemia is the most common cancer in children and teens, accounting for almost 1 out of 3 cancers. Most childhood leukemias are acute...
March 2022: According to Johnson & Johnson, a therapy developed by the company and its China-based partner Legend Biotech Corp to treat a kind of white...
March 2022: HIFU (High Intensity Focused Ultrasound) is a cutting-edge therapy that uses focused, high-energy ultrasound waves to heat and kill cancerous parts...
March 2022: A revolutionary approach to CAR-T Cell therapy has the potential to overturn what has become a medical axiom: that the treatment’s remarkable...
March 2022: The Food and Drug Administration has approved olaparib (Lynparza, AstraZeneca Pharmaceuticals, LP) for the adjuvant treatment of adult patients...
March 2022: In the neoadjuvant setting, the FDA approved nivolumab (Opdivo, Bristol-Myers Squibb Company) in combination with platinum-doublet chemotherapy...
March 2022: After four or more prior lines of therapy, including a proteasome inhibitor (PI), an immunomodulatory agent (IMiD), and an anti-CD38 monoclonal...
March 2022: Tebentafusp-tebn (Kimmtrak, Immunocore Limited), a bispecific gp100 peptide-HLA-directed CD3 T cell engager, has been licenced by the Food and Drug...
March 2022: Abatacept (Orencia, Bristol-Myers Squibb Company) has been approved by the Food and Drug Administration for the prevention of acute graft versus...
March 2022: The University of Texas MD Anderson Cancer Center researchers discovered that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR...
March 2022: The Food and Drug Administration has approved rituximab (Rituxan, Genentech, Inc.) in conjunction with chemotherapy for CD20-positive diffuse...
March 2022: Daratumumab + hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) and carfilzomib (Kyprolis, Amgen, Inc.) plus dexamethasone have been...
Dec 2020: The University of Texas MD Anderson Cancer Center researchers discovered that axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T cell...
Dec 2021: CAR T-Cell therapy is at present approved for some forms of leukemia, lymphoma and multiple myeloma. Researchers are now also developed the...
Feb 2022: In China, a patient whose life was on the verge of ending was entirely healed of leukaemia thanks to CAR T-cell therapy, which stimulated the immune...
4th Feb 2022: In India, cancer can have serious social and economic effects, typically resulting in family destitution and societal injustice. In this...
Jan 2022: Pafolacianine (Cytalux, On Target Laboratories, LLC), an optical imaging agent, has been licenced by the Food and Drug Administration for adult...
Jan 2022: Pembrolizumab (Keytruda, Merck) has been approved by the Food and Drug Administration for the adjuvant treatment of patients with renal cell...
Nov 2021: The Food and Drug Administration has approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment in patients with stage II to IIIA...
Nov 2021: Pembrolizumab (Keytruda, Merck) in conjunction with chemotherapy, with or without bevacizumab, has been approved by the Food and Drug Administration...
October 2021: The Food and Drug Administration has approved abemaciclib (Verzenio, Eli Lilly and Company) in combination with endocrine therapy (tamoxifen or...
October 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) has been approved by the Food and Drug Administration for adult patients with relapsed or...
October 2021: After failure of one or two lines of systemic therapy, the Food and Drug Administration approved ruxolitinib (Jakafi, Incyte Corp.) for chronic...
October 2021: The FDA has given tisotumab vedotin-tftv (Tivdak, Seagen Inc.), a tissue factor-directed antibody and microtubule inhibitor combination, rapid...
October 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) has been approved by the Food and Drug Administration for adult and paediatric patients 12 years of age...
September 2021: The FDA granted accelerated approval to mobocertinib (Exkivity, Takeda Pharmaceuticals, Inc.) for adult patients with locally advanced or...
Sept 19, 2021: The Food and Drug Administration approved Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) for adult patients with previously treated, locally...
July 25, 2021: Kite, a Gilead Company (Nasdaq: GILD), today announced that the FDA has granted TecartusTM (brexucabtagene autoleucel, formerly KTE-X19), the...
August 2021: Nivolumab (Opdivo, Bristol-Myers Squibb Co.) has been approved by the Food and Drug Administration for the adjuvant treatment of patients with...
August 2021: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) was given accelerated approval by the Food and Drug Administration for adult patients with...
August 2021: Belzutifan (Welireg, Merck), a hypoxia-inducible factor inhibitor, has been approved by the Food and Drug Administration for adult patients with...
August 2021: The combination of lenvatinib (Lenvima, Eisai) and pembrolizumab (Keytruda, Merck) has been approved by the Food and Drug Administration for the...
August 2021: Pembrolizumab (Keytruda, Merck) was approved by the FDA for high-risk, early-stage triple-negative breast cancer (TNBC) as a neoadjuvant treatment...
August 2021: Pembrolizumab (Keytruda, Merck) in combination with lenvatinib (Lenvima, Eisai) has been approved by the Food and Drug Administration for patients...
August 2021: Daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) have been approved by the Food and Drug Administration in combination...
August 2021: Enfortumab vedotin-ejfv (Padcev, Astellas Pharma US, Inc.), a Nectin-4-directed antibody and microtubule inhibitor combination, has been approved...
August 2021: The Food and Drug Administration has approved asparaginase erwinia chrysanthemi (recombinant)-rywn) (Rylaze, Jazz Pharmaceuticals, Inc.) as part...
August 2021: The FDA approved avapritinib (AyvakitTM, Blueprint Medicines Corp.) for adult patients with advanced systemic mastocytosis (AdvSM), which includes...
August 2021: Infigratinib (Truseltiq, QED Therapeutics, Inc.), a kinase inhibitor, has been granted accelerated approval by the Food and Drug Administration...
August 2021: The FDA granted accelerated approval to sotorasib (LumakrasTM, Amgen, Inc.), a RAS GTPase family inhibitor, for adult patients with KRAS G12C...
August 2021: The FDA granted amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.), a bispecific antibody directed against epidermal growth factor (EGF) and MET...
August 2021: The FDA has approved Nivolumab (Opdivo, Bristol-Myers Squibb Company) for patients with fully resected oesophagus or gastroesophageal junction...
August 2021: Pembrolizumab (Keytruda, Merck & Co.) in combination with trastuzumab, fluoropyrimidine-, and platinum-containing chemotherapy has been...
August 2021: The FDA granted loncastuximab tesirine-lpyl (Zynlonta, ADC Therapeutics SA), a CD19-directed antibody and alkylating agent conjugate, accelerated...
August 2021: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) received accelerated approval from the Food and Drug Administration for adult patients with...
August 2021: For advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, the Food and Drug Administration...
August 2021: Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) was given accelerated approval by the Food and Drug Administration for patients with locally...
August 2021: Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) gained regular FDA clearance for patients with unresectable locally advanced or metastatic...
August 2021: The Food and Drug Administration approved idecabtagene vicleucel (Abecma, Bristol Myers Squibb) for the treatment of adult patients with relapsed...
August 2021: Pembrolizumab (Keytruda, Merck Sharp & Dohme Corp.) in combination with platinum and fluoropyrimidine-based chemotherapy has been approved by...
August 2021: The first oral gonadotropin-releasing hormone (GnRH) receptor antagonist, relugolix (ORGOVYX, Myovant Sciences, Inc.), was approved by the Food...
August 2021: Tivozanib (Fotivda, AVEO Pharmaceuticals, Inc.), a kinase inhibitor, has been approved by the FDA for adult patients with relapsed or refractory...
August 2021: Lorlatinib (Lorbrena, Pfizer Inc.) received regular FDA approval for patients with metastatic non-small cell lung cancer (NSCLC) whose tumours are...
August 2021: The FDA has given axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) expedited approval for adult patients with relapsed or refractory...
August 2021: Lorlatinib (Lorbrena, Pfizer Inc.) received regular FDA approval for patients with metastatic non-small cell lung cancer (NSCLC) whose tumours are...
August 2021: Melphalan flufenamide (Pepaxto, Oncopeptides AB) in combination with dexamethasone has been granted accelerated approval by the Food and Drug...
August 2021: The FDA approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) for the first-line treatment of patients with advanced non-small cell...
August 20, 2021: The FDA has given cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals, Inc.) regular approval for patients with locally advanced basal cell...
August 20, 2021: Recently in May, 2021 Lumakras (sotorasib) was approved by the US Food and Drug Administration as the first treatment for adult patients with...
July 2021: The American Cancer Society has modified its cancer preventive diet and physical activity guidelines. A person’s lifetime risk of acquiring or...
July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any...
July 13th 2021: A novel medication for people with a kind of liver cancer called hepatocellular carcinoma is available that appears to be better than standard...
July 12th 2021: Beta-thalassemia is an inherited condition caused by mutations in a gene involved in the production of a component of haemoglobin, the protein...
July 2021: Breyanzi (lisocabtagene maraleucel; liso-cel), a novel CD19-directed chimeric antigen receptor (CAR) T cell treatment developed by Bristol Myers...
July 9th 2021: During the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021, two scientists from Roswell Park...
July 7th 2021 : Tobacco smoking is the leading cause of lung cancer, accounting for over 80% of all fatalities from the disease. People who do not smoke,...
July 6th 2021 : Colorectal cancer is the among most prevalent cause of cancer death in the the world. Regular screening, on the other hand, can detect...
June 2021 : As per our resources a hospital in China has developed CAR T-Cell therapy for T-cell acute lymphoblastic leukaemia (T-ALL). The expressing protein...
Acquired Immonodeficiency syndrome (AIDS) is a potentially life threatening condition caused by Human Immunodeficiency Virus (HIV) and is transmitted from...
Trifluridine/tipiracil tablets (LONSURF, Taiho Pharmaceutical Co., Ltd.) were approved by the Food and Drug Administration on February 22, 2019 for adult...
On February 6, 2019, in conjunction with plasma exchange and immunosuppressive treatment, the Food and Drug Administration approved caplacizumab-yhdp (CABLIVI,...
Bone marrow transplant Bone marrow transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high...
Check the cost of medical treatment in Turkey. Thousands of patients from nearby countries visit Turkey for medical treatment. Before visiting Turkey...
Check the cost of medical treatment in South-Korea. Thousands of patients from nearby countries visit South-Korea for medical treatment. Before visiting...
Check the cost of medical treatment in Singapore. Thousands of patients from nearby countries visit Singapore for medical treatment. Before visiting...
Check the cost of medical treatment in Japan. Thousands of patients from nearby countries visit Japan for medical treatment. Before visiting Japan for...
Check the cost of medical treatment in China. Thousands of patients from nearby countries visit China for medical treatment. Before visiting China for...
Check the cost of medical treatment in Israel. Thousands of patients visit Israel for medical treatment every year. Before visiting Israel for medical...
Check the cost of medical treatment in India. More than 5,00,000 patients visited India for medical treatment in 2019 alone. Before visiting India for...
A Queensland University of Technology (QUT) researcher is developing a simple saliva test to detect human papillomavirus (HPV) in laryngeal cancer. This is...
According to the results announced at the 2018 ASCO annual meeting, the CDK4/6 inhibitors pabociclib (Ibrance) and cetuximab (Erbitux) combined treatment of...
At the 96th Congress of the International Association for Dental Research (IADR), Benjamin Chaffee of the University of California, San Francisco published a...
Even with surgery, radiotherapy, chemotherapy, and/or gene-targeted therapy (such as cetuximab), the five-year survival rate for locally advanced head and...
According to a new study by Stanford University School of Medicine, a compound found in citrus oil may help relieve dry mouth symptoms caused by radiation...
Scientists at the University of California, San Francisco have discovered a common genetic driver of aggressive meningioma, which can help clinicians detect...
Compared with other malignant tumors such as non-small cell lung cancer (NSCLC) and breast cancer, head and neck squamous cell carcinoma (HNSCC) is relatively...
Mr. Xu is a typical Chongqing native. He is naturally spicy and unhappy. Among all the spicy foods, Chongqing spicy hot pot is his favorite. However,...
People are familiar with the uncomfortable feeling of acid reflux. A recent US study found that gastroesophageal reflux disease (GORD) may increase the risk...
The California Department of Public Health issued guidelines on cell phone radiation and how to reduce exposure. According to the CBS report, although there is...
The University of Athens Strati A et al. reported that whether PD-L1 is overexpressed in circulating tumor cells (CTC) can provide more feasible and important...
The report by Kershena Liao of Baylor College of Medicine in the United States and more fully understand the process of head and neck oncologists considering...
Neuroendocrine tumors are rare, accounting for less than 1% of all malignant tumors, and most of them occur in the stomach, intestines, and pancreas. The most...
Experts from CancerFax can assist patients to directly consult with experts in major proton centers to determine the suitability of patients for proton...
The research team of Shenzhen Hospital collected 37 samples of bladder cancer patients, performed whole exon sequencing and gene editing techniques, and...
Gastrointestinal stromal tumor targeting drug Avapritinib (Avapriny, Ayvakit, BLU-285) is approved by USFDA on 9th January, 2020. The drug covers two...
Colon cancer immunotherapy, rectal cancer immunotherapy, colorectal cancer immunotherapy, colorectal cancer PD-1 / PD-L1 treatment. Seventeen years ago, the...
How to prevent relapse of colorectal cancer, how to treat relapse of colorectal cancer after surgery? Colorectal cancer is a common malignant tumor,...
Intestinal cancer self-test, how to check intestinal cancer, colorectal cancer screening, rectal cancer check, what check for rectal cancer, what check for...
In the past two years, with the deepening of research related to targeting and immunotherapy and genotyping, more and more drugs with good effects and fewer...
Medical personnel worldwide are developing new human antigen vaccines, including various types of cancer preventive and therapeutic. Click for details: The...
Before the start of the article, the first look at science. Understanding of MSI-H, MSS, MSI-L MSS (MicroSatellite stability), microsatellite stability,...
BRAF mutations occur in 15% of colorectal patients. There are no targeted drugs approved by the FDA so far, and the prognosis is poor. Among them, BRAF V600E...
The theme of the 2019 NCCN Annual Meeting is to expand biomarker testing to guide the precise treatment of cancer, as well as new changes to colorectal cancer...
Immunotherapy uses drugs to help the body’s own immune system better recognize and destroy cancer cells. Immunotherapy can be used to treat patients...
Colorectal cancer is one of the most common malignant tumors. In China, the incidence of colorectal cancer is ranked 4th and 3rd among men and women,...
Regular exercise, maintaining a healthy weight, and avoiding tobacco products are all lifestyle choices that help reduce the risk of cancer. Healthy eating is...
In all anti-cancer and anti-cancer science articles, we can see the importance of exercise. It can not only promote a healthy lifestyle, but also change the...
According to a recent study published in JAMA Oncology, obesity is associated with an increased risk of early-onset colorectal cancer (CRC) in women. A...
According to the CDC, colorectal cancer is the third most common cancer diagnosed in the United States and the second leading cause of cancer death in the...
Among patients with bowel cancer, nearly half of the cases can be prevented by lifestyle changes. Of the 42,000 people diagnosed each year, 95% are over 50...
Appendic cancer is very rare, accounting for less than 1% of gastrointestinal tumors, and there is little scientific data on the disease, which means that the...
A new study describes themechanistic relationship between thecytokine interleukin-1β(IL-1β) and obesity. WhenIL-1βlevels increase in obesity, theactivation...
According to a new study by the American Cancer Society, patients with colorectal cancer who eat a healthy diet have a reduced risk of dying from colorectal...
For many years, doctors have been confused about why colon cancer can develop in people who find nothing on colonoscopy. A new discovery from Oklahoma Medical...
Chronic inflammation is a predisposing factor for colorectal cancer, which is the third leading cause of cancer-related deaths in the United States. Dr. Anna...
Obesity is on the rise worldwide and is related to the incidence of colon cancer , but its mechanism has been a mystery. In a new study, Yale University...
Nut-rich diets, such as walnuts, have been shown to play a role in heart health and reducing colorectal cancer. According to a new study, the impact of...
The American Cancer Society estimates that more than 97,000 people in the United States will be diagnosed with colorectal cancer this year and will cause...
In previous studies, researchers have clarified how taking aspirin can help prevent bowel cancer. This study found that analgesics block key processes related...
In a study published online on April 6 in Cancer, the prevalence of depression and anxiety increased among patients with colorectal cancer (CRC). The team of...
According to the latest clinical data, a single pre-genome test is more effective for Lynch syndrome in patients with colorectal cancer (CRC) than traditional...
The latest shows that a diet without red meat significantly reduces the risk of colon cancer in British women. Researchers at the University of Leeds evaluated...
“About 5-6 years ago, we started to see some young patients with colorectal cancer, including some people in their 20s or 30s, which had never been seen...
According to the results of a unique global clinical trial study, some patients with stage III colon cancer who undergo surgical resection of their tumors and...
https://www.youtube.com/watch?v=wxYnqkqkkFM Click the following link to discover more about best hospitals in India for lung cancer treatment please check out:...
A study from the University of Cincinnati School of Medicine at the Annual Cancer Symposium on Surgical Oncology in Chicago on March 24, 2018 showed that...
Scientists report that a small daily dose of Viagra can significantly reduce the risk of colorectal cancer in animal models, which is the third leading cause...
In 2017, a study published in the Journal of the National Cancer Institute stated that among young people aged 20-50 years, the incidence of rectal cancer is ...
The FoundationOne CDx (F1CDx) cancer biomarker detection method was approved by the FDA in November 2017 to detect 324 different genes that can identify...
New research shows that in patients with liver or liver-dominant metastatic colorectal cancer , the addition of selective internal radiation therapy to...
According to the CALGB 8903 study published in the Journal of Clinical Oncology, patients with stage III colon cancer who eat at least 2 servings of nuts per...
According to a study by the University College London (UCL) on how nematodes and microorganisms treat drugs and nutrients, the activity of anticancer drugs...
In a study of mice, scientists from the University of California, Los Angeles, David Geffen School of Medicine found that raising cholesterol levels in animals...
Gastrointestinal adverse reactions are one of the most common side effects including radiotherapy, chemotherapy, targeting and other treatments. Most of the...
Japanese researchers have developed an artificial intelligence system that extends an endoscope with a magnification of 500 times into the patient ’s...
Researchers from Harvard University found evidence in a new study that colon cancer cells carry certain bacteria when they metastasize to other organs in the...
What is the disease of rectal cancer? Colorectal cancer is one of the five most common cancers in the world. The other four types of cancer are lung cancer,...
A new study reported at the European Digestive Disease Week (UEG) shows that regardless of family history, colorectal cancer screening has doubled since the...
A Swedish study showed that vaccination with cholera after diagnosis of colorectal cancer can reduce the risk of colorectal cancer-related death and all-cause...
A systematic review and me of Sakuraba and other reports from the University of Chicagota analysis results show that patients with chronic liver disease have a...
Researchers at Memorial Sloan Kettering Cancer Center and the Massachusetts Institute of Technology have developed a new three-step system that uses nuclear...
Mingyang Song of Harvard Medical School and Massachusetts General Hospital reported that after diagnosis of non-metastatic colorectal cancer, ingesting more...
Colorectal cancer The researchers found that adding SIRT to chemotherapy can improve the survival rate of colorectal cancer New research shows that for...
TNM staging system One tool doctors use to describe cancer staging is the TNM system. Doctors use the results of diagnostic tests and scans to answer the...
Rectal cancer is cancer that occurs in the last few inches of the colon. This area is called the rectum. The main treatment for rectal cancer is surgery....
The 2017 Annual Meeting of the American Society of Oncology (ASCO) will be held in Chicago on June 2, local time. At 12 noon on May 17, local time, ASCO held...
The concept of oligometastasis was proposed by Hellman in 1995. He pointed out that the lesion refers to some intermediate states between the localized...
At the 18th World Congress of Gastrointestinal Cancer, a phase I clinical study showed that anti-PD-L1 immunotherapy combined with MEK inhibitors can...
Targeting drugs such as cetuximab and panitumumab have been widely used in clinic as effective therapeutic drugs for colorectal cancer. Clinical data show...
Japanese pharmaceutical company Otsuka (Otsuka) recently received good news in the US regulatory aspects, FDA approved anti-cancer compound new drug Lo 3...
Because leukemia classification and prognosis stratification are complex, there is no one-size-fits-all treatment method, and it is necessary to combine...
On June 17-20, 2015, the 13th International Lymphoma Conference was successfully held in Switzerland. 3700 representatives from 90 countries participated in...
A review written by Young, MD, Anderson Cancer Center, USA explained the application of PD-1 inhibitor immunotherapy in B-cell lymphoma. (Blood. Online...
A new study from McMaster University in Canada said that it has discovered a new treatment strategy for acute myeloid leukemia. By stimulating the production...
The Cleveland Clinic of the United States Eric D. His et al. Reported that the diagnosis of peripheral T cell lymphoma (PTCL) in the United States varies...
Acalabrutinib is a second-generation tyrosine kinase (BTK) inhibitor, a newer drug that can improve the survival of chronic lymphocytic leukemia (CLL) and...
Mature T-cell tumors, such as non-Hodgkin T-cell lymphoma, are highly invasive and drug-resistant, and patients often have a poor prognosis. Recently,...
Obesity not only runs counter to the aesthetics of Chinese people, but also causes many chronic diseases. Some studies have shown that body mass index (BMI)...
A study conducted at the Los Angeles Children ’s Hospital is providing the best treatment for a rare invasive leukemia called mixed phenotype acute leukemia...
Yesterday, the US FDA announced the approval of Seattle Genetics’ antibody-drug conjugate Adcetris (brentuximab vedotin) in combination with chemotherapy...
According to the results of a 5-year follow-up of the key PACE trial published in the Journal of Hematology, panatinib (Ponatinib, Iclusig) has maintained...
New Cleveland Clinic research shows for the first time that FDA-approved ibrutinib (ibrutinib) for lymphoma and leukemia may also help treat the most common...
Bosutinib is a Src / Abl dual tyrosine kinase inhibitor approved for the treatment of newly diagnosed chronic phase (CP) chronic myelogenous leukemia (CML), or...
The latest research found that some statins can improve the efficacy of chemotherapy drugs used to treat blood cancer in mouse models. Statins are drugs that...
Bone marrow fibrosis is a rare chronic disease of bone marrow hematopoietic cells. They benefit from JAK2 inhibitor drugs: symptom relief, prolonged survival,...
On June 8 , the US FDA approved Venetoclax ( VENCLEXTA , AbbVie Inc. and Genentech Inc. ) for patients with chronic lymphocytic leukemia ( CLL ) or small...
On June 12-13, FDA approved two new indications for K drug, just the day before the K drug was approved for the treatment of cervical cancer. One day later,...
In the United States, more than 70,000 people are diagnosed with non-Hodgkin’s lymphoma each year, which is caused by excessive proliferation of immune...
In recent years, the effect of immune checkpoint inhibitors on the treatment of Hodgkin’s lymphoma (HL) is impressive, but the disease still needs to be...
Researchers at the University of California, San Francisco and St. Jude Children ’s Research Hospital in Tennessee have solved medical mysteries decades ago,...
The US Food and Drug Administration approved Venetoclax (Venclexta) combined with rituximab (VenR) for the treatment of patients with chronic lymphocytic...
According to a multi-center clinical trial led by researchers at the Stanford University School of Medicine, a new type of immunotherapy seems to be safe for...
According to the results of the second phase of the study, the combination of standard-care chemotherapy drug azacitidine and the immune checkpoint inhibitor...
On November 28, FDA approved the first rituximab (Rituxan, rituximab) biosimilar, Truxima (rituximab-abbs, Celltrion Inc.) for non-Hodgkin’s lymphoma...
The US FDA has approved gilteritinib ( Xospata ) for the treatment of adult patients with FLT3 mutation-positive relapse or refractory acute myeloid...
The results of a multi-center phase III clinical trial showed that if elderly patients with chronic lymphocytic leukemia ( CLL ) are treated with a new...
Venetoclax ( Venclexta ) and rituximab ( Rituxan ) are used in combination with relapsed / refractory chronic lymphocytic leukemia ( CLL ), resulting...
Leukemia In the clinical field of medicine, leukemia is also called blood cancer and belongs to the category of malignant tumors. It is mainly divided into two...
Lymphoma Many people think that their body resistance is high, and think that malignant tumors such as lymphoma are still far away from us. In fact, in recent...
Lymph People have very little knowledge of lymph. The neck, groin, and armpits are all lymph. If there is a problem with the lymphatic system, the body’s...
People who know nothing about leukemia are the most frightened. They will definitely mix sepsis and leukemia. They think this is a disease. In fact, these are...
Lymph Lymph is distributed throughout the body and is intricate. Generally speaking, the first thing people think of is the neck. In fact, there are both...
Lymphoma The lymph in the human body is actually complicated. Lymphoma is the fastest and the highest death in malignant tumors, because the lymphatic system...
Rusotinib tablets (ruxolitinib / Jakafi) for the treatment of bone marrow fibrosis with moderate or high risk, including primary bone marrow fibrosis,...
T cell- acute lymphocytic leukemia (T-ALL) T cell- acute lymphocytic leukemia (T-ALL) is a highly progressive malignant hematological tumor with a poor...
Sarcoma treatment, how to treat sarcoma, sarcoma gene sequencing, Foundation medicine gene detection, sarcoma targeted therapy, sarcoma targeted medicine Why...
Scientists at Michigan State University are designing a virus-like particle called Qβ, which will generate an anti-cancer immune response in the body and may...
In addition to rapid and lasting weight loss and other health benefits, bariatric surgery is now associated with a 61% reduced risk of malignant melanoma,...
Scientists at Trinity College Dublin (TCD) have developed a new therapy that can help treat the most common rare soft tissue sarcoma affecting young...
On October 19, 2016, the new drug Olaratumab passed the accelerated approval of the US FDA and could be combined with doxorubicin to treat specific types of...
In recent decades, monoclonal antibody-based cancer treatment has been established as one of the most successful treatment strategies for solid tumors and...
George D. Demetri and others from the American Dana Fabre / Briegen and Women ’s Hospital Cancer Center reported that among patients with liposarcoma, the...
What is sarcoma? Sarcoma is a rare connective tissue tumor, so sarcoma can invade any part of our body. These tumors include liposarcoma, neurosarcoma,...
In September 2015, a child patient with rhabdomyosarcoma in Guangdong, China successfully completed proton radiotherapy at the Proton Center of the Eastern...
On July 10, 2015, the National Cancer Institute (NCI) announced that the largest precision medicine clinical trial in history has begun to recruit patients....
Sarcoma, which occurs in young people and is a malignant tumor derived from mesenchymal tissue (including connective tissue and muscle). Sarcomas are highly...
Precise radiotherapy is the most important method of cancer treatment. Precise radiotherapy techniques represented by rapid front knife, proton knife, heavy...
According to the latest report from the US Centers for Disease Control and Prevention (CDC), the incidence of almost all cancers has declined in the past two...
With the continuous improvement of living standards, the age of people’s sexual organ development also continues to decrease. More and more people have...
Everyday I will hear that cervical erosion will become cancerous when it is severe. In fact, not all of them will become cancerous. It can only be said that...
In recent years, the incidence of gynecological tumors has increased year by year, making the terms cervical cancer and ovarian cancer no longer unfamiliar to...
Uterine cancer According to the latest report from the US Centers for Disease Control and Prevention (CDC), the incidence of almost all cancers has declined in...
Since the 1960s, due to the popularity of screening, cervical cancer deaths have declined significantly. In the United States, cervical cancer is the 18th...
Medical experts say that 90% of cancer patients are caused by unhealthy life habits, not DNA plays a leading role. Diet, sunlight, smoking, and disease have a...
Immunotherapy has brought promising breakthroughs to several types of cancer. Cervical cancer has a relatively large number of mutations (gene changes), which...
Pap smears can help reduce the incidence of cervical cancer. A new study shows that they can also be used to detect other gynecological cancers early. The...
Although more than 12,000 women in the United States are diagnosed with cervical cancer every year and about 4,000 people die of cervical cancer, cervical...
The FDA says that although cervical cancer kills about 4,000 women in the United States each year, most cervical cancers are preventable. Moreover, if the...
For moderate cervical lesions-abnormal cells on the surface of the cervix (commonly called cervical intraepithelial neoplasia grade 2 or CIN2), routine...
1. The importance of cervical cancer screening in women during pregnancy Juvenile laryngeal papilloma is more common in children and adolescents, mainly...
Studies reported by the University of California, Tewari et al. Showed that with the extension of follow-up time, the overall survival curves of patients in...
Screening of cervical cancer Is it safe to extend the screening interval to 5 years or more after a negative screening result? A new study shows that the risk...
Cancer experts at the City of Hope, California Center for Cancer Therapy and Research, said that in fact, the more women know about the disease, the greater...
One of the longest-lasting female contraceptive methods and one of the best methods may provide unexpected health benefits for women using this method. A new...
Cervicitis is a very common gynecological disease, and many people begin to worry after diagnosis of cervicitis: Will cervicitis worsen into cervical...
Is there an age limit for vaccinating cervical cancer? The first approved HPV vaccine for preventing cervical cancer was officially launched in the market....
Cervical cancer Chronic cervicitis is more common than after delivery, miscarriage or surgical injury to the cervix, pathogens (mainly staphylococcus,...
Condyloma acuminatum general treatment Western medicine treatment of condyloma acuminatum. Since there are no special antiviral drugs, the treatment of...
Treatment of condyloma acuminatum 1. Cryotherapy: Using freezing method can make the condyloma acuminatum freeze, forming a local high degree of edema of the...
Condyloma acuminatum disease is a very contagious disease, and the common site of this disease is around the genitals, and this part is often more fragile,...
Condyloma acuminatum What should I pay attention to during the treatment of genital warts? Condyloma acuminatum is a relatively serious sexually transmitted...
Victoria L. Chiou, an oncologist at the National Cancer Institute ’s Women ’s Malignancies Department, reported a phase I trial at AACR2015. The results...
Cervical cancer According to the statistics of the World Health Organization in 2012, there are nearly 530,000 new cases of cervical cancer worldwide each...
Adolescent obesity is associated with many health problems in later life, and a large Israeli study has shown that the increased risk of fatal pancreatic...
The survival rate of pancreatic cancer is very low. In the past 40 years, the survival rate has not changed significantly. Finding effective treatments is an...
Specific molecular signals released by pancreatic cancer cells have been determined. Pancreatic cancer is usually detected after the disease has spread, and...
In a recent interview, Dr. Afsaneh Barzi, assistant professor of clinical medicine at the University of Southern California Norris Comprehensive Cancer Center,...
New research has found that pancreatic cancer cells rely heavily on a protein to grow and spread. The research results can bring new treatment and prevention...
A recent study published in the journal Cellular and Molecular Gastroenterology and Hepatology showed that a gene mutation called ATRX may lead to an increased...
Dr. Thomas A. Steitz died on October 9, 2018 at the age of 78, and died of pancreatic cancer. Steitz is the co-winner of the 2009 Nobel Prize in Chemistry....
Ruiwen Zhang and Robert L. Boblitt from the University of Houston have developed a new pancreatic cancer drug. The research was published in the Journal of...
A recent study published in the European Journal of Clinical Nutrition showed that diet may play a key role in preventing pancreatic cancer. The study...
Pancreatic neuroendocrine tumors (NETs) usually grow slowly, and the laboratory monitors the tumor for signs of growth through imaging tests. Patients with...
Pancreatic cancer can invade and press nerves near the pancreas, which may cause abdominal or back pain in patients with pancreatic cancer. Pain specialists...
18 March 2020 In January 2020 the World Health Organization (WHO) declared the outbreak of a new coronavirus disease, COVID-19, to be a Public Health Emergency...
The pancreas is located in the abdomen, behind the lower stomach. The pancreas releases enzymes that help the body digest food, and it also releases hormones...
A research team from the Abramson Cancer Center (ACC) at the University of Pennsylvania School of Medicine found that whether a tumor is hot or cold is...
The pancreas is an oblong organ located deep in the abdomen and is a component of the digestive system and endocrine system. It secretes hormones to regulate...
Pancreatic cancer Pancreatic cancer, also known as the king of cancer, is one of the common malignant tumors of the digestive system. In recent years, both...
At the 2018 ASCO conference, the results of a study on chemotherapy attracted a lot of attention. Studies have shown that an innovative chemotherapy can...
In the largest genome-wide pancreatic cancer study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute and...
Research reported by researchers at Fudan University shows that a new combination of four protein biomarkers can accurately diagnose pancreatic cancer . (Br...
According to Jabbar et al. Of the University of Gothenburg in Sweden, targeted mass spectrometry based on only three biomarkers of cyst fluid can highly...
Investigative research suggests that diet may affect the risk of pancreatic cancer. The study investigated the effect of a low-fat diet on the incidence of...
Pancreatic cancer is a malignant tumor with extremely high degree of harm, and pancreatic cancer will have different signs at different periods. Although...
Pancreatic cancer: diagnosis If the doctor suspects that someone has pancreatic cancer, he will first ask the patient’s medical history, family medical...
In the fall of 2015, 44-year-old Doron Broman was diagnosed with pancreatic cancer -and was surprised to find that his pancreatic cancer had metastasized to...
Early diagnosis of pancreatic cancer is difficult and lacks specific drugs. Recently, researchers from France and Spain have discovered that a substance...
Pancreatic cancer Pancreatic cancer is a malignant tumor of the digestive tract that is highly malignant and difficult to diagnose and treat. About 90% is...
Pancreatic cancer is a malignant tumor of the digestive tract that is highly malignant and difficult to diagnose and treat. It is hailed as the “king of...
Pancreatic cancer is currently one of the most deadly and chemotherapy-resistant cancers. Recently, cancer researchers in Australia have developed a very...
Pancreatic cancer targeted drug, pancreatic cancer BRCA mutation targeted drug olaparib (Olaparib, Liprot Lynparza) received FDA expert support Due to the...
Pancreatic Cancer According to statistics in 2014, the estimated number of new cases of pancreatic cancer in developed countries (the United States) is ranked...
Gastric adenocarcinoma is also a relatively common type of cancer, and its incidence is relatively high in China. There are many ways to treat gastric...
Gastric cancer & chemotherapy Chemotherapy is also one of the commonly used treatment methods for malignant tumors in the clinic. After chemotherapy, there...
Food taken by the human body will enter the small intestine area through the throat, and then digest and absorb through the small intestine and the large...
Due to the long-term irregular diet or love to eat spicy and irritating food, many young people are faced with gastroenteritis. If left unattended, it will...
Genetic testing for gastric cancer After nearly ten years of development, tumor genetic testing has become the immediate need of a large number of cancer...
Gastric cancer is growing Gastric cancer remains one of the most common and deadly cancers worldwide, especially among older males. Based on GLOBOCAN 2018...
Gastritis and gastric cancer Severe inflammation in certain tissues and organs of the body is usually related to the occurrence of cancer, but the mechanism of...
Researchers at the Duke University Cancer Institute have found that H. pylori may lead to an increased risk of colorectal cancer, especially for people with...
Lutathera (Lutetium 177) is the first radiopharmaceutical approved by the FDA for the treatment of certain gastrointestinal and pancreatic cancers. Every...
A research team led by the National University Health System (NUHS) and Duke University School of Medicine used genomic technology to better understand...
Gastric cancer immunotherapy is still an exciting research area, especially the pd-1 inhibitors pembrolizumab (Keytruda) and nivolumab (Nivolumab, Opdivo). In...
It is not difficult to reduce the mortality rate of gastric cancer in a certain year, but it is difficult to continuously reduce it for 60 years. What did...
Related studies have found that patients with gastric cancer have obvious family aggregation: the first-degree relatives (ie parents and siblings) of gastric...
The anterior lobe of the transverse colon and the pancreatic capsule and the serous membrane of the stomach originate from the same germ layer, and together...
The recent ONO-4538-12 clinical study released at the ASCO-GI conference showed that compared with placebo, Nivolumab reduced the risk of death of patients by...
The following is the stage analysis and conventional treatment plan for gastric cancer published on the American cancer website. TNM staging system for...
Advanced gastric cancer Gastric cancer has long been in the lead in terms of morbidity and mortality of malignant digestive tract tumors. The biggest reason is...
Although PD-1 immunotherapy has opened a new model of tumor treatment, and has a good performance in the treatment of non-small cell lung cancer (NSCLC),...
Gastric cancer patients Introduction: After clinical treatment of gastric cancer patients, in order to prevent recurrence and metastasis in the rehabilitation...
Key points for diagnosis and treatment of tumors at the junction of gastroesophagus 1 Gastroesophageal junction (GEJ) adenocarcinoma occurs at the junction of...
Recently, the Global Oncologist Network reported that a patient with advanced cardia cancer liver metastasis has successfully survived for three years after...
The 2016 NCCN Clinical Guidelines for Gastric Cancer updated the systemic treatment plan for metastatic or locally advanced gastric cancer in the first edition...
The 2016 American Conference of Clinical Oncology (ASCO) is about to be held in Chicago as one of the most talked about academic conferences in the field of...
According to the results of a large multicenter clinical trial led by scientists and scientists at the Dana Faber Cancer Research Center, after standard...
Immunotherapy and cancer treatment In recent years, the popularity of immunotherapy in the field of oncology is continuing to rise. Lancet Oncol published...
According to statistics, patients with gastric cancer treated in the United States, Europe, and Japan are often recommended to use ramucirumab in combination...
What to do about drug resistance of non-small cell lung cancer targeted drugs, you want to know here Lung cancer is the cancer with the highest morbidity and...
Lung cancer immunotherapy, lung cancer immunotherapy, lung cancer PD-1 treatment, lung cancer PD-L1 treatment are all you want to know. In the past two years,...
Dong-Wan Kim scholars from the Seoul National University Hospital in South Korea will give an oral report on the special meeting of metastatic non-small cell...
Lung cancer and proton therapy The lungs are adjacent to some of the most sensitive and important organs and tissues, including the heart, esophagus, and...
Lung cancer is one of the most common causes of human death due to tumors, and its morbidity and mortality rate have ranked first in cities. The pathology is...
The results of the LUX-Lung 7 study show that a head-to-head Phase IIb clinical study compared afatinib and gefitinib in the treatment of tumors with EGFR...
The second edition of the 2016 NCCN Guidelines for Small Cell Lung Cancer (V2.2016) mainly updates the following parts based on V2.2015: Lung cancer...
Registration: ClinicalTrials.gov Last updated: January 25, 2016 Main ID: NCT02659059 Registration Date: January 15, 2016 Main sponsor: Bristol-Myers Squibb...
Lung cancer problem Perhaps it is because of the direct feeling of the respiratory system. As the haze continues, we feel more and more people suffering from...
The US Food and Drug Administration (hereinafter referred to as FDA) approved Portrazza (necitumumab) in combination with gemcitabine and cisplatin in the...
MPDL3280A, which retains the PD-L2 / PD-1 interaction, potentially reduces autoimmune lung toxicity, and has a good effect on advanced NSCLC. Platinum-based...
Treatment of non-small cell lung cancer The treatment of lung cancer mainly uses surgery, radiotherapy and chemotherapy, and surgery is still the most...
Non-small cell lung cancer and brain metastasis Previously, non-small cell lung cancer (NSCLC) brain metastases have a poor prognosis, with a median survival...
Cancer genetic testing Cancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform...